156 related articles for article (PubMed ID: 36619620)
21. Annual outpatient hysteroscopy and endometrial sampling (OHES) in HNPCC/Lynch syndrome (LS).
Manchanda R; Saridogan E; Abdelraheim A; Johnson M; Rosenthal AN; Benjamin E; Brunell C; Side L; Gessler S; Jacobs I; Menon U
Arch Gynecol Obstet; 2012 Dec; 286(6):1555-62. PubMed ID: 22865035
[TBL] [Abstract][Full Text] [Related]
22. Clinical outcome of atypical endometrial hyperplasia diagnosed on an endometrial biopsy: institutional experience and review of literature.
Rakha E; Wong SC; Soomro I; Chaudry Z; Sharma A; Deen S; Chan S; Abu J; Nunns D; Williamson K; McGregor A; Hammond R; Brown L
Am J Surg Pathol; 2012 Nov; 36(11):1683-90. PubMed ID: 23073327
[TBL] [Abstract][Full Text] [Related]
23. Laparoscopic Surgery for Atypical Endometrial Hyperplasia with Awareness Regarding the Possibility of Endometrial Cancer.
Kamii M; Nagayoshi Y; Ueda K; Saito M; Takano H; Okamoto A
Gynecol Minim Invasive Ther; 2023; 12(1):32-37. PubMed ID: 37025442
[TBL] [Abstract][Full Text] [Related]
24. Prediction of endometrial carcinogenesis probability while diagnosed as atypical endometrial hyperplasia: a new risk model based on age, CA199 and CA125 assay.
Zhou L; Meng Z; Wu Y; Zhu H; Wang X
Eur J Obstet Gynecol Reprod Biol; 2014 Dec; 183():5-9. PubMed ID: 25461342
[TBL] [Abstract][Full Text] [Related]
25. Can malignant potential of endometrial polyps be determined by incorporating the endometrial intraepithelial neoplasia (EIN) classification?
Naaman Y; Diment J; Perlman S; Oustinov N; Vaisbuch E; Ben-Arie A
Gynecol Oncol; 2015 Feb; 136(2):254-7. PubMed ID: 25524459
[TBL] [Abstract][Full Text] [Related]
26. Endometrial Cancer Incidence in Patients With Atypical Endometrial Hyperplasia According to Mode of Management.
Barakat A; Ismail A; Chattopadhyay S; Davies Q
Cancer Diagn Progn; 2022; 2(5):564-568. PubMed ID: 36060021
[TBL] [Abstract][Full Text] [Related]
27. Endometrial evaluation with transvaginal ultrasonography for the screening of endometrial hyperplasia or cancer in premenopausal and perimenopausal women.
Kim MJ; Kim JJ; Kim SM
Obstet Gynecol Sci; 2016 May; 59(3):192-200. PubMed ID: 27200309
[TBL] [Abstract][Full Text] [Related]
28. Risk of More Advanced Lesions at Hysterectomy after Initial Diagnosis of Non-Atypical Endometrial Hyperplasia in Patients with Postmenopausal Bleeding and Oral Anticoagulant Treatment.
Carabineanu A; Zaharia C; Blidisel A; Ilina R; Miclaus C; Ardelean O; Preda M; Mazilu O
Medicina (Kaunas); 2021 Sep; 57(10):. PubMed ID: 34684040
[No Abstract] [Full Text] [Related]
29. Clinical Predictive Factors of Response to Treatment in Patients Undergoing Conservative Management of Atypical Endometrial Hyperplasia and Early Endometrial Cancer.
Raffone A; Travaglino A; Flacco ME; Iasevoli M; Mollo A; Guida M; Insabato L; Di Spiezio Sardo A; Carugno J; Zullo F
J Adolesc Young Adult Oncol; 2021 Apr; 10(2):193-201. PubMed ID: 32799597
[No Abstract] [Full Text] [Related]
30. Analysis of endometrial lavage microbiota reveals an increased relative abundance of the plastic-degrading bacteria
Chao A; Chao AS; Lin CY; Weng CH; Wu RC; Yeh YM; Huang SS; Lee YS; Lai CH; Huang HJ; Tang YH; Lin YS; Wang CJ; Wu KY
Front Cell Infect Microbiol; 2022; 12():1031967. PubMed ID: 36439209
[TBL] [Abstract][Full Text] [Related]
31. Factors predictive of endometrial carcinoma in patients with atypical endometrial hyperplasia on preoperative histology.
Touboul C; Piel B; Koskas M; Gonthier C; Ballester M; Cortez A; Daraï E
Anticancer Res; 2014 Oct; 34(10):5671-6. PubMed ID: 25275072
[TBL] [Abstract][Full Text] [Related]
32. Mismatch repair-deficiency specifically predicts recurrence of atypical endometrial hyperplasia and early endometrial carcinoma after conservative treatment: A multi-center study.
Raffone A; Catena U; Travaglino A; Masciullo V; Spadola S; Della Corte L; Piermattei A; Insabato L; Zannoni GF; Scambia G; Zullo F; Bifulco G; Fanfani F; Di Spiezio Sardo A
Gynecol Oncol; 2021 Jun; 161(3):795-801. PubMed ID: 33812697
[TBL] [Abstract][Full Text] [Related]
33. Levonorgestrel-releasing intrauterine system for endometrial hyperplasia.
Mittermeier T; Farrant C; Wise MR
Cochrane Database Syst Rev; 2020 Sep; 9(9):CD012658. PubMed ID: 32909630
[TBL] [Abstract][Full Text] [Related]
34. [Results of treatment of atypical endometrial hyperplasia].
Tabakman IuIu; Al-Khalabi A; Vasil'eva IA
Akush Ginekol (Mosk); 1987 Jul; (7):35-7. PubMed ID: 3688327
[TBL] [Abstract][Full Text] [Related]
35. Histopathology of women with non-uniform endometrial echogenicity and risk factors for atypical endometrial hyperplasia and carcinoma.
Cong Q; Luo L; Fu Z; Lu J; Jiang W; Sui L
Am J Transl Res; 2021; 13(5):4500-4509. PubMed ID: 34150030
[TBL] [Abstract][Full Text] [Related]
36. Live births and maintenance with levonorgestrel IUD improve disease-free survival after fertility-sparing treatment of atypical hyperplasia and early endometrial cancer.
Novikova OV; Nosov VB; Panov VA; Novikova EG; Krasnopolskaya KV; Andreeva YY; Shevchuk AS
Gynecol Oncol; 2021 Apr; 161(1):152-159. PubMed ID: 33461741
[TBL] [Abstract][Full Text] [Related]
37. [Atypical epithelial hyperplasia of the breast: current state of knowledge and clinical practice].
Lavoué V; Bertel C; Tas P; Bendavid C; Rouquette S; Foucher F; Audrain O; Bouriel C; Levêque J
J Gynecol Obstet Biol Reprod (Paris); 2010 Feb; 39(1):11-24. PubMed ID: 19853386
[TBL] [Abstract][Full Text] [Related]
38. Direct uterine sampling with the Tao brush sampler using a liquid-based preparation method for the detection of endometrial cancer and atypical hyperplasia: a feasibility study.
Kipp BR; Medeiros F; Campion MB; Distad TJ; Peterson LM; Keeney GL; Halling KC; Clayton AC
Cancer; 2008 Aug; 114(4):228-35. PubMed ID: 18548528
[TBL] [Abstract][Full Text] [Related]
39. The Value of Shear Wave Elastography in Predicting the Risk of Endometrial Cancer and Atypical Endometrial Hyperplasia.
Ma H; Yang Z; Wang Y; Song H; Zhang F; Yang L; Yan N; Zhang S; Cai Y; Li J
J Ultrasound Med; 2021 Nov; 40(11):2441-2448. PubMed ID: 33433027
[TBL] [Abstract][Full Text] [Related]
40. Is repeated high-dose medroxyprogesterone acetate (MPA) therapy permissible for patients with early stage endometrial cancer or atypical endometrial hyperplasia who desire preserving fertility?
Yamagami W; Susumu N; Makabe T; Sakai K; Nomura H; Kataoka F; Hirasawa A; Banno K; Aoki D
J Gynecol Oncol; 2018 Mar; 29(2):e21. PubMed ID: 29400014
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
